[CYCC] QoQ Quarter Result on 30-Jun-2012 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -21.05%
YoY- -0.70%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 212 5 38 146 161 175 164 18.64%
PBT -3,356 -5,067 -3,572 -3,704 -3,123 -3,780 -3,571 -4.05%
Tax -258 -637 -419 -127 -168 -122 -126 61.17%
NP -3,082 -4,764 -1,890 -3,577 -2,955 -3,658 -3,445 -7.14%
Tax Rate - - - - - - - -
Total Cost 3,294 4,769 1,928 3,723 3,116 3,833 3,609 -5.90%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin -1,453.77 -95,280.00 -4,973.68 -2,450.00 -1,835.40 -2,090.29 -2,100.61 -21.74%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
EPS -75.55 -149.01 -53.81 -101.86 -90.66 -113.25 -107.75 -21.05%
EPS Diluted -75.55 -149.01 -53.81 -101.86 -90.66 -112.22 -107.75 -21.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.